XT
APGE

XTX Topco’s Apogee Therapeutics APGE Stock Holding History

XTX Topco’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
20,666
-22,233
-52% -$2M 0.04% 812
2026
Q1 		$3.61M Buy
42,899
+23,873
+125% +$1.73M 0.06% 456
2025
Q4 		$1.44M Buy
19,026
+13,174
+225% +$830K 0.04% 769
2025
Q3 		$233K Sell
5,852
-6,469
-53% -$247K 0.01% 1721
2025
Q2 		$535K Sell
12,321
-4,867
-28% -$185K 0.02% 1050
2025
Q1 		$642K Buy
17,188
+10,840
+171% +$419K 0.03% 841
2024
Q4 		$288K Buy
+6,348
New +$324K 0.02% 1254
2024
Q3 		– Sell
-17,930
Closed -$706K – 2067
2024
Q2 		$706K Buy
+17,930
New +$870K 0.06% 497

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

XTX Topco's APGE Position: Q2 2026 in Review

XTX Topco reduced its Apogee Therapeutics (APGE) stake by 52% in Q2 2026, selling an estimated $2M and leaving 20,666 shares worth $2.74M. The position accounts for 0.04% of the portfolio, ranked #812.

XTX Topco first reported a position in APGE in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.61M in Q1 2026. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • XTX Topco held 20,666 shares of Apogee Therapeutics worth $2.74M as of Q2 2026.
  • XTX Topco sold 22,233 Apogee Therapeutics shares in Q2 2026, an estimated $2M.
  • Apogee Therapeutics made up 0.04% of XTX Topco's portfolio in Q2 2026, its #812 holding.
  • XTX Topco first reported a position in Apogee Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • XTX Topco's Apogee Therapeutics position peaked at $3.61M in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.